David Tyssen

1.8k total citations
28 papers, 1.4k citations indexed

About

David Tyssen is a scholar working on Virology, Infectious Diseases and Microbiology. According to data from OpenAlex, David Tyssen has authored 28 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Virology, 17 papers in Infectious Diseases and 9 papers in Microbiology. Recurrent topics in David Tyssen's work include HIV Research and Treatment (17 papers), HIV/AIDS drug development and treatment (15 papers) and Reproductive tract infections research (9 papers). David Tyssen is often cited by papers focused on HIV Research and Treatment (17 papers), HIV/AIDS drug development and treatment (15 papers) and Reproductive tract infections research (9 papers). David Tyssen collaborates with scholars based in Australia, United States and South Africa. David Tyssen's co-authors include Gilda Tachedjian, Richard A. Cone, Muriel Aldunate, Secondo Sonza, Anna C. Hearps, Thomas R. Moench, Raffi Gugasyan, David Jose Delgado-Diaz, Adam Johnson and Joshua A. Hayward and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

David Tyssen

27 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Tyssen Australia	16	479	451	396	394	345	28	1.4k
Fred C. Krebs United States	26	428 0.9×	325 0.7×	518 1.3×	380 1.0×	647 1.9×	76	1.9k
André Désormeaux Canada	23	391 0.8×	149 0.3×	242 0.6×	168 0.4×	268 0.8×	41	1.1k
Derek H. Owen United States	15	181 0.4×	487 1.1×	315 0.8×	220 0.6×	176 0.5×	22	1.6k
Pedro M. M. Mesquita United States	21	129 0.3×	529 1.2×	556 1.4×	400 1.0×	448 1.3×	27	1.2k
Mohammad Reza Aghasadeghi Iran	24	711 1.5×	128 0.3×	529 1.3×	635 1.6×	361 1.0×	185	2.1k
Yonghou Jiang United States	20	306 0.6×	205 0.5×	561 1.4×	154 0.4×	325 0.9×	48	1.3k
Che‐Chung Tsai United States	25	378 0.8×	251 0.6×	1.4k 3.6×	1.2k 3.1×	1.5k 4.2×	63	3.0k
Nadia R. Roan United States	28	627 1.3×	433 1.0×	679 1.7×	303 0.8×	688 2.0×	80	2.3k
Christophe Vanpouille United States	29	1.1k 2.2×	405 0.9×	652 1.6×	612 1.6×	836 2.4×	71	2.5k
Amy Martin United States	26	650 1.4×	240 0.5×	629 1.6×	315 0.8×	431 1.2×	43	1.7k

Countries citing papers authored by David Tyssen

Since Specialization

Citations

This map shows the geographic impact of David Tyssen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Tyssen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Tyssen more than expected).

Fields of papers citing papers by David Tyssen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Tyssen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Tyssen. The network helps show where David Tyssen may publish in the future.

Co-authorship network of co-authors of David Tyssen

This figure shows the co-authorship network connecting the top 25 collaborators of David Tyssen. A scholar is included among the top collaborators of David Tyssen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Tyssen. David Tyssen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aldunate, Muriel, David Tyssen, Adam Johnson, et al.. (2025). Lactic acid produced by optimal vaginal Lactobacillus spp. potently and specifically inactivates HIV-1 in vitro by targeting the viral RNA genome and reverse transcriptase. PLoS Pathogens. 21(10). e1013594–e1013594.

Dawson, Shane, Adam Johnson, Menachem J. Gunzburg, et al.. (2023). Targeting HIV-1 Reverse Transcriptase Using a Fragment-Based Approach. Molecules. 28(7). 3103–3103. 4 indexed citations

Tyssen, David, Anna C. Hearps, Kalyani Guntur, et al.. (2022). The Impact of Over-The-Counter Lactic Acid Containing Vaginal Gels on the Integrity and Inflammatory State of the Vaginal Epithelium in vitro. SHILAP Revista de lepidopterología. 4. 915948–915948. 6 indexed citations

Delgado-Diaz, David Jose, David Tyssen, Joshua A. Hayward, et al.. (2020). Distinct Immune Responses Elicited From Cervicovaginal Epithelial Cells by Lactic Acid and Short Chain Fatty Acids Associated With Optimal and Non-optimal Vaginal Microbiota. Frontiers in Cellular and Infection Microbiology. 9. 446–446. 106 indexed citations

Kaminskas, Lisa M., Charlotte C. Williams, Linda J. Chan, et al.. (2019). A 30 kDa polyethylene glycol-enfuvirtide complex enhances the exposure of enfuvirtide in lymphatic viral reservoirs in rats. European Journal of Pharmaceutics and Biopharmaceutics. 137. 218–226. 10 indexed citations

Hearps, Anna C., David Tyssen, Lois Bayigga, et al.. (2017). Vaginal lactic acid elicits an anti-inflammatory response from human cervicovaginal epithelial cells and inhibits production of pro-inflammatory mediators associated with HIV acquisition. Mucosal Immunology. 10(6). 1480–1490. 155 indexed citations

Danial, Maarten, Sushama Telwatte, David Tyssen, et al.. (2016). Combination anti-HIV therapy via tandem release of prodrugs from macromolecular carriers. Polymer Chemistry. 7(48). 7477–7487. 25 indexed citations

Hearps, Anna C., Raffi Gugasyan, David Tyssen, et al.. (2014). Lactic Acid, a Vaginal Microbiota Metabolite, Elicits an Anti-inflammatory Response from Vaginal and Cervical Epithelial Cells. AIDS Research and Human Retroviruses. 30(S1). A238–A239. 8 indexed citations

Aldunate, Muriel, David Tyssen, Catherine F. Latham, et al.. (2014). Vaginal Concentrations of Lactic Acid Potently Inactivate HIV-1 Compared to Short Chain Fatty Acids Present During Bacterial Vaginosis. AIDS Research and Human Retroviruses. 30(S1). A228–A228. 6 indexed citations

10.

Aldunate, Muriel, David Tyssen, Adam Johnson, et al.. (2013). Vaginal concentrations of lactic acid potently inactivate HIV. Journal of Antimicrobial Chemotherapy. 68(9). 2015–2025. 131 indexed citations

11.

Price, Clare F., David Tyssen, Secondo Sonza, et al.. (2011). SPL7013 Gel (VivaGel®) Retains Potent HIV-1 and HSV-2 Inhibitory Activity following Vaginal Administration in Humans. PLoS ONE. 6(9). e24095–e24095. 136 indexed citations

12.

Telwatte, Sushama, Adam Johnson, David Tyssen, et al.. (2011). Virucidal activity of the dendrimer microbicide SPL7013 against HIV-1. Antiviral Research. 90(3). 195–199. 79 indexed citations

13.

Cherry, Catherine L., Steve Wesselingh, Randi Fain, et al.. (2010). Ubisol-AquaTM: Coenzyme Q10 Prevents Antiretroviral Toxic Neuropathy in an In Vitro Model. Current HIV Research. 8(3). 232–239. 4 indexed citations

14.

Tyssen, David, Scott Henderson, Adam Johnson, et al.. (2010). Structure Activity Relationship of Dendrimer Microbicides with Dual Action Antiviral Activity. PLoS ONE. 5(8). e12309–e12309. 132 indexed citations

15.

Fahey, Jonathan M., Mark Zanin, David Tyssen, et al.. (2007). N348I in the Connection Domain of HIV-1 Reverse Transcriptase Confers Zidovudine and Nevirapine Resistance. PLoS Medicine. 4(12). e335–e335. 138 indexed citations

16.

Keller, Paul A., et al.. (2003). Novel pharmacophore-based methods reveal gossypol as a reverse transcriptase inhibitor. Journal of Molecular Graphics and Modelling. 21(5). 365–373. 34 indexed citations

17.

Druce, Julian, et al.. (2002). Utility of a Multiplex PCR Assay for Detecting Herpesvirus DNA in Clinical Samples. Journal of Clinical Microbiology. 40(5). 1728–1732. 60 indexed citations

18.

Jardine, Darren, David Tyssen, & Christopher J. Birch. (2000). Effect of protease inhibitors on HIV-1 maturation and infectivity. Antiviral Research. 45(1). 59–68. 7 indexed citations

19.

Birch, Chris, David Tyssen, Gilda Tachedjian, et al.. (1992). Clinical Effects and In Vitro Studies of Trifluorothymidine Combined with Interferon- for Treatment of Drug-Resistant and -Sensitive Herpes Simplex Virus Infections. The Journal of Infectious Diseases. 166(1). 108–112. 47 indexed citations

20.

Tachedjian, Gilda, David Tyssen, Stephen Locarnini, Ian D. Gust, & Christopher Birch. (1990). Investigation of Topoisomerase Inhibitors for Activity against Human Immunodeficiency Virus: Inhibition by Coumermycin A1. Antiviral chemistry & chemotherapy. 1(2). 131–138. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact